Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-09 Sale | 2020-11-12 6:30 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 39,391 | $91.79 | $3,615,680 | 4,807,997 (Indirect Direct) | View |
| 2020-11-02 Sale | 2020-11-04 8:53 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 40,000 | $90.59 | $3,623,600 | 4,887,388 (Indirect Direct) | View |
| 2020-09-23 Sale | 2020-09-25 7:00 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 25,535 | $99.73 | $2,546,625 | 4,788,606 (Indirect Direct) | View |
| 2020-09-16 Sale | 2020-09-18 6:25 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $101.58 | $4,063,200 | 4,814,141 (Indirect Direct) | View |
| 2020-09-09 Sale | 2020-09-11 9:21 pm | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 40,000 | $102.73 | $4,109,200 | 4,854,141 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-03 Other | 2021-12-07 9:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Director | 3,500,008 | $0 | 4,843,413 (Indirect) | View |
| 2021-12-03 Other | 2021-12-07 9:09 pm | N/A N/A | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 124,999 | $0 | 212,696 (Indirect) | View |
| 2021-06-01 Option Award | 2021-06-02 7:33 pm | N/A 2031-06-01 | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 3,571 | $0 | 3,571 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 7:22 pm | N/A 2031-02-23 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 41,714 | $0 | 41,714 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 6:30 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 39,391 | $26.45 | 4,807,997 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 6:30 pm | N/A 2022-03-09 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner | 39,391 | $0 | 4,807,997 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 8:53 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 40,000 | $26.45 | 4,887,388 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 8:53 pm | N/A 2022-03-09 | Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman | 40,000 | $0 | 4,887,388 (Direct) | View |
| 2020-07-27 Option Award | 2020-07-29 9:18 pm | N/A 2030-07-26 | Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director | 1,492 | $0 | 1,492 (Direct) | View |